Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
1.
Rev. chil. obstet. ginecol. (En línea) ; 85(supl.1): S101-S105, set. 2020. tab
Article in Spanish | LILACS | ID: biblio-1138654

ABSTRACT

INTRODUCCIÓN: Las alteraciones del perfil hepático durante el embarazo ocurren en 3-5% de las gestantes. Una nueva etiología que se ha presentado en el contexto de pandemia actual es el síndrome respiratorio agudo severo relacionado con el nuevo coronavirus (SARS-CoV-2). Éste es responsable de alteraciones hepáticas en 2 a 11% de la población general infectada por este virus, y de hasta un 30% en las embarazadas que se infectan con SARS-CoV-2. Con el objetivo de mostrar una presentación poco frecuente del SARS-CoV-2 se expone un caso clínico de elevación de transaminasas en embarazada inducida por este nuevo virus. CASO CLÍNICO: Paciente de 36 años, cursando embarazo de 20+6 semanas, consulta por dolor abdominal asociado a ictericia y coluria. Se solicita estudio donde destaca elevación de transaminasas. Ecografía abdominal con vía biliar fina. Se descartan diferentes etiologías de hepatitis aguda y crónica (dada la falta de antecedentes). Finalmente se solicita PCR para COVID-19 que resulta positiva. CONCLUSIÓN: Luego de un estudio exhaustivo de diferentes etiologías de elevación de transaminasas, se atribuye esta alteración enzimática a SARS-CoV-2. Se decide seguimiento ambulatorio estricto con pruebas hepáticas cada dos semanas. La paciente evoluciona estable con exámenes normales luego de un mes desde que se indica el alta hospitalaria. Después de descartar etiologías frecuentes de elevación de transaminasas durante el embarazo, sugerimos solicitar el estudio de este virus con PCR para COVID-19, ya que podría ser una presentación poco frecuente de SARS-CoV-2.


INTRODUCTION: Approximately 3-5% of women present alterations of hepatic enzymes during pregnancy. Under the new circumstances that the world is facing with the SARS-COV2 pandemic, a new etiology for hepatic enzyme alterations has risen. The severe acute respiratory syndrome that the novel coronavirus causes is responsible for hepatic enzyme alterations in 2 to 11% of the sick population that did not have a previous underlying hepatic condition. Furthermore, hepatic enzyme alterations in pregnant women infected with SARS-COV2 presents in up to 30% of the cases. An infrequent presentation of SARS-COV2 is presented as our clinical case. CLINICAL CASE: A 36-year-old patient with a 20+6 week pregnancy presents abdominal pain, jaundice and choluria. General blood workup shows elevated transaminases. The abdominal ultrasound revealed a thin bile duct. Acute and chronic hepatitis etiologies were discarded. Finally, a PCR of COVID-19 was solicited, which turned out to be positive. CONCLUSIÓN: After an exhaustive study to determine the etiology of the elevated transaminases, the hepatic alterations were attributed to SARS-COV2 infection. A conservative management was adopted, with outpatient follow-up with liver testing every two weeks. The patient progresses with a stable steady decline in hepatic enzyme levels, and one-month post hospital discharge, her transaminases had reached normal values. Based on this clinical case, after ruling out frequent etiologies for elevated transaminases during pregnancy, it seems reasonable to request a PCR for COVID-19, since it could be a rare presentation of SARS-CoV-2.


Subject(s)
Humans , Female , Pregnancy , Adult , Pneumonia, Viral/complications , Pregnancy Complications, Infectious/enzymology , Pregnancy Complications, Infectious/etiology , Coronavirus Infections/complications , Betacoronavirus , Pneumonia, Viral/enzymology , Transferases/analysis , Coronavirus Infections/enzymology , Alkaline Phosphatase/analysis , Pandemics , Jaundice , Liver Diseases/enzymology , Liver Diseases/etiology
2.
Rev. chil. pediatr ; 88(1): 169-175, 2017. ilus, tab
Article in Spanish | LILACS | ID: biblio-844593

ABSTRACT

Las fosfatasas alcalinas (FA) son un grupo de 4 isoenzimas que se producen en diversos tejidos, pudiendo elevarse en condiciones fisiológicas y secundariamente a enfermedades óseas o hepatobiliares. En niños una de las causas más frecuentes e inocuas, pero poco conocidas, es la hiperfosfatasemia transitoria benigna de la infancia (HFTBI). El objetivo es reportar una serie de casos de HFTBI y proponer un criterio de enfrentamiento. Casos clínicos: Se presentan 5 niños de entre 11 y 50 meses de edad, 4 de ellos de sexo femenino, con hallazgo incidental de elevación severa (> 1.000 UI/l) en los niveles de FA en exámenes solicitados por mal incremento pondo-estatural o por cuadros infecciosos. A través de la anamnesis, examen físico y laboratorio básico se descartó enfermedad ósea o hepática. En 2 de los pacientes se determinaron las isoenzimas, destacando el predominio óseo. Se comprobó una normalización de los niveles de FA en un periodo de uno a 6 meses, sin evidencia de complicaciones posteriores. Conclusión: La HFTBI es un desorden bioquímico benigno de evolución autolimitada, que es importante tener presente al enfrentar un niño menor de 5 años con elevación severa de FA, en ausencia de alteraciones clínicas o de laboratorio que sugieran enfermedad ósea o hepática.


Alkaline Phosphatase (ALP) is a group of 4 isoenzymes produced in different tissues. Elevated levels of ALP can be developed under physiological conditions, and can indicate the presence of bone or hepatobiliary diseases. In children, one of its most common harmless causes is benign transient hyperphosphatasaemia (BTH), a little known condition. The objective is to report BTH cases and propose a monitoring plan. Case reports: The cases of 5 children aged between 11 and 50 months are presented, 4 of them female, with the incidental finding of a sudden and severe ALP elevation (> 1,000 U/l), in tests ordered due to either abnormal growth and development, or intercurrent infections. Bone and liver disease were ruled out using the patient history, physical examination and basic laboratory results. Isoenzymes levels were determined in 2 patients. A return to normal ALP levels was observed over a period of 1-6 months, with no evidence of further complications. Conclusion: BTH is a benign self-limiting biochemical disorder, which should be considered in children under 5 years old with severe ALP elevation in the absence of clinical or laboratory abnormalities suggestive of bone or liver disease.


Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Bone Diseases/diagnosis , Alkaline Phosphatase/blood , Liver Diseases/diagnosis , Time Factors , Bone Diseases/enzymology , Retrospective Studies , Isoenzymes/blood , Liver Diseases/enzymology
3.
Rev. méd. Chile ; 144(8): 1078-1082, ago. 2016. ilus, tab
Article in Spanish | LILACS | ID: biblio-830612

ABSTRACT

We report an asymptomatic 23-year-old woman with an isolated and persistent increase in serum levels of aspartate aminotransferase (AST). An extensive work up including laboratory and image testing revealed no abnormalities thus suggesting the presence of macro-AST. A polyethylene glycol (PEG) precipitation assay was performed and confirmed the presence of macro-AST.


Subject(s)
Humans , Female , Young Adult , Aspartate Aminotransferases/blood , Alanine Transaminase/blood , Autoimmune Diseases/diagnosis , Autoimmune Diseases/enzymology , Liver Diseases/diagnosis , Liver Diseases/enzymology
4.
Rev. gastroenterol. Perú ; 33(3): 262-264, jul.-set. 2013. ilus, graf, tab
Article in Spanish | LIPECS, LILACS, LIPECS | ID: lil-692448

ABSTRACT

En este artículo hacemos una revisión de las causas más frecuentes de elevación de los niveles de las aminotransferasas, fosfatasa alcalina y gamma glutamil transpeptidasa en personas aparentemente sanas, al mismo tiempo ofrecemos una orientación sencilla que facilite al médico general una orientación escueta que permita el diagnóstico y manejo adecuado de estos casos.


In this study we make a review of the most common causes of the rise of the levels of aminotransferases, alkaline fosphatase and gamma glutamil transpeptidase en healthy people, also we offer a view of the diagnosis and management of these patients as simple as possible.


Subject(s)
Humans , Alkaline Phosphatase/blood , Liver Diseases/blood , Liver Diseases/enzymology , Liver/enzymology , Transaminases/blood , gamma-Glutamyltransferase/blood , General Practitioners , Liver Diseases/diagnosis
5.
Rev. méd. Chile ; 141(7): 909-916, jul. 2013. ilus
Article in Spanish | LILACS | ID: lil-695772

ABSTRACT

Background: Determination of Alanine aminotransferase serum levels ([ALT]s) is a sensitive ana reliable test for liver diseases. Aim: To report the prevalence of abnormal [ALT]s in Chilean population and to identify associated variables. Methods: We analyzed data from a random sub-sample of 2,794 adults surveyed during the second Chilean National Health Survey. Abnormal [ALT]s were defined by using three different cut-off values (COV), two fixed COV (COV1: > 30 IU/L in men and > 19 IU/L in women and COV2 pre-defined by the performing laboratory) and a COV adjusted by age, weight and sex (COV3 > 31 IU/L for women and > 44 IU/L and men > 42 IU/L and > 66 IU/L with a BMI > 23). Logistic regression analysis was performed to determine risk factors for elevated [ALT]s Results: Mean [ALT]s values were 30.14 I U/L in men and 22.03 IU/L in women. The observed prevalence of abnormal [ALT]s defined by different COV were 38%, 11.5%, and 8.1% for COV1, COV2 and COV3 respectively. Variables independently associated to abnormal [ALT]s in a multivariate analysis were the following: serum gamma-glutamyl-transpeptidase (OR: 1.055 [95% CI 1.033-1.078]) and body mass index (OR:1.13 [95% CI 1.09-1.17]). Variables inversely associated with abnormal [ALT]s (COV1) were mole gender (OR-.0.976 [95% CI 0.96-0.99) and HDL-cholesterol (OR:0979 [95% CI 0.96-0.99]). Conclusions: Independently of the COV used, Chilean population exhibits a high prevalence of abnormal [ALT]s which may reflect a significant burden of liver disease. Non-alcoholic fatty liver disease could be a major contributor to elevated [ALT]s considering the association of abnormal [ALT]s and metabolic variables.


Subject(s)
Adult , Female , Humans , Male , Alanine Transaminase/blood , Biomarkers/blood , Chile , Health Surveys , Liver Diseases/diagnosis , Liver Diseases/enzymology , Prevalence , Reference Values , Risk Factors , Sensitivity and Specificity
6.
Journal of Gorgan University of Medical Sciences. 2011; 13 (2): 123-129
in Persian | IMEMR | ID: emr-117398

ABSTRACT

Celiac disease is one of the most common cause of malabsorption syndrome. The symptom of this disease associated secondary to malabsorbtive problems. Celiac can be accompanied with liver enzyme dysfunction with various extra intestinal findings. This case was a 27-year old man presented with abnormal liver function test over period of 1 year. He did not have another symptom such as diarrhea, weight loss or skin lesion. In medical examination, there was no ascites, peripheral edema or jaundice. Diagnostic re-examination of the patient include serology tests and Viral hepatitis, Wilson disease and auto imuune responses showed to be normal. Abdominal and biliary sonography had normal results. Liver biopsy revealed no sign of any pathology, but duodenal biopsy and serologic findings were compatible by Celiac disease. The symptom improved on a gluten-free diet and his liver enzyme function tests became normal subsequently


Subject(s)
Humans , Male , Malabsorption Syndromes/etiology , Liver Diseases/enzymology , Liver Function Tests
7.
Rev. Soc. Bras. Med. Trop ; 43(1): 1-3, Jan.-Feb. 2010. tab, ilus
Article in English | LILACS | ID: lil-540502

ABSTRACT

INTRODUCTION: to evaluated the type histopathological hepatic lesions and opportunistic agents in Brazilian HIV-infected patients. METHODS: we examined 52 percutaneous liver biopsies of 50 HIV-infected patients who had at least two of the following conditions: fever of unknown origin, unexplained severe emaciation, hepatomegaly or abnormal liver chemistry. The specimens were cultured for mycobacteria and fungi and stained by standard procedures. RESULTS: reactive patterns, granulomatous hepatitis and chronic active hepatitis were verified in 28 (54 percent), 11 (21 percent) and 8 (15 percent) of the patients respectively. Opportunistic infections were diagnosed in 18 (36 percent) patients: mycobacteria in 12 (24 percent), Cryptococcus neoformans in 5 (10 percent) patients and mycobacteria and yeast was isolated from the same liver fragment in one patient. CONCLUSIONS: mycobacteriosis was the most common opportunistic infection and liver tissue culture is an important method to detect opportunistic agents, even in the absence of histological lesions.


INTRODUÇÃO: avaliar os tipos de lesões histopatológicas e infecções oportunistas de Brasileiros infectados pelo HIV. MÉTODOS: Foram analisadas 52 biópsias hepáticas percutâneas de 50 pacientes que apresentavam pelo menos duas das alterações: febre de origem indeterminada, emagrecimento inexplicado, hepatomegalia ou anormalidades na bioquímica hepática. O fragmento de tecido hepático foi submetido a histopatologia por métodos habituais e cultura para micobacteria e fungo. RESULTADOS: padrão reacional, hepatite granulomatosa e hepatite crônica ativa foram encontrados em 28 (54 por cento), 11 (21 por cento) e 8 (15 por cento) dos pacientes respectivamente. Infecções oportunistas foram diagnosticadas em 18 (36 por cento) dos pacientes: micobacteria em 12 (24 por cento), Cryptococcus neoformans em 5 (10 por cento) pacientes e micobacteria e fungo foram isolados no mesmo fragmento em um paciente. CONCLUSÕES: micobacteriose foi a infecção oportunista mais comum e a cultura de tecido hepático foi um importante método para detecção de infecções, mesmo na ausência de lesões histológicas.


Subject(s)
Adolescent , Adult , Female , Humans , Male , Middle Aged , Young Adult , AIDS-Related Opportunistic Infections/pathology , Liver Diseases/pathology , Liver/pathology , Brazil , Fever of Unknown Origin/etiology , Liver Diseases/enzymology , Liver Diseases/etiology , Liver/enzymology , Mycobacterium Infections/pathology , Young Adult
8.
Saudi Journal of Gastroenterology [The]. 2010; 16 (2): 79-83
in English | IMEMR | ID: emr-125513

ABSTRACT

Paraoxonase 1 [PON1] is an esterase, exclusively synthesized by liver. The present study has two objectives: to determine the PON1 activity status in various disorders associated with hepatocellular damage and to correlate the changes of PON1 activity with the standard liver function and fasting lipid profile tests in these disorders. The study groups consisted of 95 patients with liver diseases including acute viral hepatitis [14], cirrhosis with portal hypertension [33], leptospirosis [14], sepsis and multi organ failure [15], left ventricular failure [9], and falciparum malaria [10]; and 53 healthy controls. Serum PON1 activity was measured manually using spectrophotometer. Liver function test parameters and fasting lipid profile were performed in clinical chemistry auto analyzer [HITACHI 912]. The serum PON1 activity in patients with acute viral hepatitis and sepsis decreased significantly [P<0.001] and moderately in falciparum malaria [P<0.05]. However, in patients with cirrhosis, leptospirosis and left ventricular patients, its activity did not change significantly. On applying Pearson correlation, serum PON1 activity correlated positively with high-density lipoprotein-cholesterol [HDL-C] in patients with sepsis [r=0.633, P<0.05], left ventricular failure patients [r=0.814, P<0.05] and negatively with acute viral hepatitis patients [r=-0.528, P<0.05]. PON1 activity has decreased significantly in acute viral hepatitis, sepsis with multi organ failure and falciparum malaria patients. Determination of PON1 activity may serve as a useful additional test in assessing these conditions


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Liver Diseases/enzymology , Hepatitis, Viral, Human/enzymology , Multiple Organ Failure/enzymology , Sepsis/enzymology , Malaria, Falciparum/enzymology
9.
Article in Korean | WPRIM | ID: wpr-89306

ABSTRACT

Anorexia nervosa, a syndrome most commonly affecting young women, is characterized by weight less than 85% of weight that is considered normal for that person's age and height, distorted body image, and fear of becoming obese, and its mortality is up to 9%. We present a case of a 33-year-old woman with a 9-year history of anorexia nervosa. She admitted to our institution with decreased mentality, and her body mass index was 11.5 kg/m2 of the time admission. Initial aminotransferase level was severely elevated, but it was normalized solely with improved nutrition and weight gain. Five and sixteen days after the admission urinary tract infection and elevation of pancreatic enzymes occurred. They were successfully treated with antibiotics and nutritional support. Fifty seven days after the admission, she discharged. We report a case of acute hepatitis and pancreatitis treated with nutritional rehabilitation in a patient with severe anorexia nervosa for the first time in Korea.


Subject(s)
Acute Disease , Adult , Alanine Transaminase/analysis , Anorexia Nervosa/complications , Aspartate Aminotransferases/analysis , Body Mass Index , Female , Humans , Lipase/analysis , Liver Diseases/enzymology , Nutrition Therapy , Pancreatic Diseases/enzymology , Weight Gain
10.
Rev. Méd. Clín. Condes ; 19(4): 412-417, sept. 2008. tab, ilus
Article in Spanish | LILACS | ID: lil-504153

ABSTRACT

La cirrosis hepática (CH) es un trastorno frecuente y con complicaciones que presentan una alta morbimortalidad. Está caracterizada por una larga fase preclínica asintomática, que puede requerir de dos décadas o más para el desarrollo de las alteraciones en la arquitectura hepática que conforman el estado cirrótico. La presencia de alteración en las pruebas hepáticas, en ausencia de síntomas y signos de enfermedad hepática, constituye un evento frecuente en la práctica médica general. Requiere de una evaluación clínica completa, con anamnesis dirigida, examen físico y estudios de laboratorio e imagenológicos; si se realizan de manera sistemática cubriendo las causas más frecuentes, su diagnóstico etiológico puede ser adecuadamente efectuado, con las consecuentes implicancias terapéuticas en algunos casos. En esta revisión se evaluarán los estudios bioquímicos actualmente disponibles para realizar un estudio clínico hepático en un paciente asintomático, su capacidad de discriminación y el estudio etiológico de las enfermedades hepáticas crónicas. Se definen además las potenciales causas hepáticas y extrahepáticas que pueden generar esta alteración.


Chronic liver diseases are a frequent medical problem and its complications are an important cause of morbidity and mortality. It is characterized by a long preclinical phase and it may take more than two decades for a liver to gain a cirrhotic architecture. In an asymptomatic patient the abnormal liver-enzyme results is a common medical problem. A good clinical history and physical examination are mandatory. If a systematic approach is adopted covering the most frequent liver disease, the cause is often apparent. In this review we discuss the battery of liver enzyme tests available in daily clinical practice, their diagnostic accuracy for the detection of liver disease and suggest an approach to abnormal tests in asymptomatic patients. The clinician should be aware of non-hepatic diseases that can cause abnormal liver enzymes.


Subject(s)
Humans , Liver Diseases/diagnosis , Liver Diseases/enzymology , Transaminases/blood , Chronic Disease , Liver Cirrhosis/enzymology , Liver Function Tests
11.
SQUMJ-Sultan Qaboos University Medical Journal. 2008; 8 (2): 185-192
in English | IMEMR | ID: emr-90410

ABSTRACT

This study was conducted to assess the relationship of hepatic enzymes and serum albumin to obesity and insulin resistance in adults in Saudi Arabia. A comparative study of 136 Saudi adults, comprising of 68 obese and 68 non-obese was conducted. Anthropometric measurements, hepatic enzymes, serum albumin, blood glucose, serum insulin, lipid profile, and homeostasis model assessment of insulin resistance [HOMA IR] were measured. The study showed significantly higher levels of gamma glutamyl transpeptidase [GGT], alkaline phosphatase, fasting glucose, serum insulin, and HOMA IR p < 0.001, <0.004 < 0.005, <0.0001, <0.0001, among obese subjects. Hepatic enzymes correlated with both anthropometric measures [body mass index [BMI], and waist to hip ratio] and markers of insulin resistance [HOMA IR, insulin, and fasting glucose]. However, the study found that GGT had the strongest associations. Significant inverse correlation was found between serum albumin and BMI, HOMA IR, and serum insulin, p< 0.01, <0.05, <0.01, respectively. Deranged liver functions, especially GGT, had the strongest correlations with obesity and HOMA IR. GGT might be a better marker of hepatic pathology associated with obesity and insulin resistance in Saudi adults with restricted alcohol intake. The results also propose that albumin metabolism might be altered in obesity


Subject(s)
Humans , Male , Female , Liver Diseases/enzymology , Liver Diseases/etiology , Insulin Resistance , Body Mass Index , Alcohol Drinking/adverse effects
12.
Biol. Res ; 41(3): 331-339, 2008. graf
Article in English | LILACS | ID: lil-511922

ABSTRACT

Cadmium (Cd) is a highly toxic environmental and industrial cumulative pollutant that affects many organs,especially the liver. The present study was designed to evaluate the antioxidant effect of green tea oncadmium-induced hepatic dysfunction and oxidative stress in rats. Adult male Wistar rats were administeredcadmium by injection of 20 ìmoles /kg bw/ every 3 days for six months. This study revealed significant (p <0.05) liver dysfunction, lipid peroxidation and a decline in antioxidant enzyme activities in the liver of cadmium-treated rats compared to control animals. Compared to control rats, the activities of lactate dehydrogenase (LDH), gammaglutamyl transferase (GGT), acid phosphatase (PAC), phosphatase alkaline (PAL), as well as bilirubin and thiobarbituric acid-reactive substances (TBARs), were significantly (p < 0.05)increased in Cd-treated rats. Moreover, antioxidant enzyme activities, such as superoxide dismutase (SOD), glutathione peroxidase (GPX) and catalase, were significantly (p < 0.05) decreased in the liver of cadmiumtreatedrats. The oral administration of 5% aqueous green tea extract, along with cadmium treatment for six months, caused a significant (p < 0.05) improvement in cadmium-induced toxicity by significantly decreasing(p < 0.05) the activities of enzymatic markers of liver dysfunction (LDH, GGT, PAC, PAL activities, as well as the bilirubin rate). Indeed, green tea extract significantly increased (p < 0.05) antioxidant enzymatic activities (SOD, Catalase, GPX) in rat liver, compared to those given cadmium alone. Thus, the oral administration of green tea, along with cadmium significantly (p < 0.05) improves cadmium-induced liverdysfunction and stress oxidant in rats’ liver.


Subject(s)
Animals , Male , Rats , Antioxidants/therapeutic use , Cadmium/toxicity , Camellia sinensis/chemistry , Lipid Peroxidation/drug effects , Liver Diseases/drug therapy , Tea , Biomarkers/blood , Free Radical Scavengers , Liver Diseases/chemically induced , Liver Diseases/enzymology , Rats, Wistar
13.
J. bras. patol. med. lab ; 41(5): 297-299, out. 2005. tab
Article in Portuguese | LILACS | ID: lil-428315

ABSTRACT

Um estudo de casos e controles, aninhado num estudo de coorte, investigou a associação entre efeitos genotóxicos e alteração de enzimas hepáticas em trabalhadores de uma refinaria de petróleo do Nordeste. Foram examinados todos os dez novos casos de alterações de enzimas hepáticas - gama-glutamil transferase (GGT) e alanina aminotransferase (ALT) - ocorridos em 2002. Dez trabalhadores sem alterações de GGT ou ALT foram selecionados como controles. Os efeitos do fumo, sexo, idade e consumo de café foram controlados. O efeito genotóxico foi avaliado pela técnica de trocas entre cromátides irmãs (TCI) e alterações cromossômicas (AC) estruturais. As médias de TCI por célula (3,92 ± 1,04 versus 4,25 ± 1,47) e de ACE (8,85 ± 3,4 versus 9,1 ± 3,7) não diferiram de forma significante entre casos e controles respectivamente.


Subject(s)
Humans , Alanine Transaminase/blood , Occupational Diseases/chemically induced , Occupational Exposure/adverse effects , Liver/enzymology , Genotype , Liver Diseases/enzymology , Liver Diseases/chemically induced , Petroleum/toxicity , Teratogens/toxicity , gamma-Glutamyltransferase/blood , Cohort Studies , Extraction and Processing Industry
15.
Acta gastroenterol. latinoam ; 29(1): 3-7, 1999. ilus, tab, graf
Article in Spanish | LILACS | ID: lil-233527

ABSTRACT

El objetivo de este trabajo es estabelecer posibles alteraciones en la glucuronización de benzodizcepinas en dos modelos experimentales de injuria hepática: La intoxicación aguda con paracetamol y la colestasis seguida de una intoxicación aguda con paracetamol. Por el contrario, los animales colestáticos seguidos de una intoxicación con paracetamol, mostraron un incremento en la glucuronización de los sustratos ensayados.


Subject(s)
Animals , Male , Acetaminophen/toxicity , Analgesics, Non-Narcotic/toxicity , Benzodiazepines/metabolism , Cholestasis , Glucuronosyltransferase/metabolism , Liver Diseases/metabolism , Acute Disease , Liver Diseases/enzymology , Rats, Wistar
16.
New Egyptian Journal of Medicine [The]. 1993; 9 (6): 1877-80
in English | IMEMR | ID: emr-30309
17.
Article in English | IMSEAR | ID: sea-94320

ABSTRACT

Twenty five patients with end stage renal disease were studied to find out the biochemical and hepatic morphological changes during short term haemodialysis. Asymptomatic hepatomegaly was seen in 32% of cases, transaminase elevation in 28% and positive Australia antigen in 12% of cases. Histopathological changes were observed in all the 12 patients in whom liver biopsy was done. Ten patients (82%) exhibited multiple abnormalities. The commonest findings were fatty change (8 patients); hepatic congestion, focal necrosis, Kupffer cell hyperplasia (6 patients each); and portal triaditis (5 patients).


Subject(s)
Adult , Aged , Female , Humans , Kidney Failure, Chronic/therapy , Liver Diseases/enzymology , Male , Middle Aged , Renal Dialysis/adverse effects , Transaminases/blood
18.
Acta bioquím. clín. latinoam ; 24(3): 195-201, sept. 1990. tab
Article in Spanish | LILACS | ID: lil-95826

ABSTRACT

A partir de la preparación de fosfatasa alcalina (EC 3.1.3.1) parcialmente purificada con etanol, de plasma de personas con grupo 0, se separaron cuatro fracciones con actividad enzimática, mediante cromatografía en columna de DEAE-celulosa, con gradiente discontinuo de NaCI. También se extrajo fosfatasa alcalina de hígado, hueso y mucosa intestinal humanos, a fin de caracterizar las distintas formas moleculares. el uso de inhibidores (L-fenil-alcalina y urea) y electroforesis en gel de poliacrilamida, permitió identificar las isoenzimas presentes en los extractos de tejidos y en los picos de elución cromatográfica de la enzima de plasma. La isoenzima hepática se encuentra en todas las fracciones. La primera eluye con NaCI 40 mM y puede separarse en dos (IA e IB). Ambas contienen las isoenzimas intestinal y ósea, además de formas parcialmente desializadas de la hepática. La segunda fracción (NaCI 60 mM) contiene exclusivamente fosfatasa alcalina hepática. La tercera (NaCI 200 mM), de alto peso molecular, está compuesta por las isoenzimas ósea, intestinal y hepática. El perfil es muy reproducible. La comparación del cromatograma correspondiente a plasma normal con el de un paciente portador de un tumor con metástasis óseas, muestra notables diferencias, indicando la utilidad diagnóstica del método, ya que permite identificar el órgano de origen, en casos de incremento de fosfatasa alcalina en plasma.


Subject(s)
Humans , Alkaline Phosphatase/blood , Chromatography, Ion Exchange , DEAE-Cellulose , Isoenzymes/isolation & purification , Bone and Bones/enzymology , Bone Diseases/enzymology , Chromatography, DEAE-Cellulose/instrumentation , Chromatography, DEAE-Cellulose/methods , Electrophoresis, Polyacrylamide Gel , Ethanol , Liver/enzymology , Intestines/enzymology , Liver Diseases/enzymology , Neuraminidase , Phenylalanine , Sodium Chloride , Urea
SELECTION OF CITATIONS
SEARCH DETAIL